Publication
The Supreme Court of Canada recently heard the appeal in R. v. Arapakota, marking the court’s first opportunity to weigh in on the interpretation of the bribery offence under the Corruption of Foreign Public Officials Act (CFPOA).
Publication
Health Canada has made important changes to how it authorizes biosimilar drugs for sale in Canada. Notably, clinical efficacy studies (i.e., phase 3 studies) comparing the efficacy of the biosimilar candidate drug to the innovative drug it copies “are not typically required.”
Publication
A requirement in a company’s by-laws for shareholders to resolve disputes through private arbitration is known as a “mandatory arbitration” clause.
Publication
Effective October 20, 2026, federally regulated employers will be required to review and possibly raise wage rates for some employees under new “Equal Treatment” wage rules.
© Norton Rose Fulbright LLP 2026
